Dali Li
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 7
- Pancreatic and Hepatic Oncology Research 5
- CAR-T cell therapy research 2
-
- Carcinogens and Genotoxicity Assessment 1
- Co-authors
- Donna L. White (1 shared paper)Zhannat Z. Nurgalieva (1 shared paper)Hashem B. El‐Serag (1 shared paper)Mingyao Liu (1 shared paper)Bing Du (1 shared paper)Juliang Qin (1 shared paper)Jiqin Zhang (1 shared paper)Ping Chang (2 shared papers)
- Journals
- Annals of Oncology (8 papers)Carcinogenesis (2 papers)Cancer Cell (1 paper)Diabetic Medicine (1 paper)American Journal of Epidemiology (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Dali Li
17 papers receiving 1.9k citations
Dali Li's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.0k
- Cancer Research 525
- Molecular Biology 714
- Immunology 146
- Surgery 283
Countries citing papers authored by Dali Li
This map shows the geographic impact of Dali Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dali Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dali Li more than expected).
Fields of papers citing papers by Dali Li
This network shows the impact of papers produced by Dali Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dali Li. The network helps show where Dali Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Dali Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients Hit paper breakdown → | 2017 | 421 |
| 2 | 2011 | 316 | |
| 3 | 2014 | 214 | |
| 4 | Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis Hit paper breakdown → | 2024 | 206 |
| 5 | 2012 | 196 | |
| 6 | 2011 | 185 | |
| 7 | CAR-T therapy in solid tumors Hit paper breakdown → | 2025 | 116 |
| 8 | 2007 | 111 | |
| 9 | 2011 | 62 | |
| 10 | 2014 | 38 | |
| 11 | 2015 | 34 | |
| 12 | 2015 | 33 | |
| 13 | 2010 | 26 | |
| 14 | 2016 | 25 | |
| 15 | 2024 | 12 | |
| 16 | 2010 | 4 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 0 |
About Dali Li
Dali Li is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Dermatology, having authored 18 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), CAR-T cell therapy research (2 papers), Hematopoietic Stem Cell Transplantation (1 paper), Carcinogens and Genotoxicity Assessment (1 paper), Immunotherapy and Immune Responses (1 paper), Effects and risks of endocrine disrupting chemicals (1 paper), Bioinformatics and Genomic Networks (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (525 citations), Molecular Biology (714 citations), Immunology (146 citations) and Surgery (283 citations). Dali Li has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Donna L. White, Zhannat Z. Nurgalieva, Hashem B. El‐Serag, Mingyao Liu, Bing Du, Juliang Qin, Jiqin Zhang, Ping Chang, Milind M. Javle and Asif Rashid. Their work appears in journals such as Annals of Oncology, Carcinogenesis, Cancer Cell, Diabetic Medicine and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.